# Silence Therapeutics

advancing an siRNA pipeline in rare blood and cardiometabolic disease on its mRNAi GOLD platform, with promising 2026 clinical results reported in its June 2026 corporate presentation.

Source: https://en.bioecon.ru/companies/silence-therapeutics/
Updated: 2026-07-11

- Country: United Kingdom
- Ticker: SLN

## Technologies

- [Nucleic acid therapeutics (oligonucleotides)](https://en.bioecon.ru/technology/nucleic-acid-therapeutics/)